ROCKLAND, Mass.--(BUSINESS WIRE)--BioSphere Medical, Inc. (NASDAQ: BSMD), the medical device company that pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a procedure called embolization, announced today that it plans to issue financial results for the second quarter on July 25, 2007 after the close of the market. Management will conduct a conference call on July 26, 2007 at 8:30 a.m. Eastern Time to discuss these results. The number to dial into the teleconference is 1-888-603-7990 or 1-706-679-7298 for international callers. The conference ID is 7237173. Please call in approximately ten minutes before the call is scheduled to begin. The call is also being webcast by Thomson Financial and can be accessed at BioSphere Medical’s web site: www.biospheremed.com.
